To print: Use your web browser's print feature. Close this window after printing.

Cryosurgery for Nonmelanoma Skin Cancer


Table of Contents


Cryosurgery for Nonmelanoma Skin Cancer

Surgery Overview

Cryosurgery is the process of destroying a skin cancer (lesion) by freezing it with liquid nitrogen. Liquid nitrogen is applied to the lesion using a cotton applicator stick or an aerosol spray.

The skin may first be numbed with a local anesthetic. The liquid nitrogen is applied or sprayed onto the cancer and the immediate surrounding tissue. The application may be repeated. An antibiotic dressing may be applied to the wound.

Cryosurgery is often used to destroy precancerous skin lesions such as actinic keratoses but is rarely used alone (monotherapy) to treat skin cancer.

What To Expect After Surgery

An area where skin tissue has been destroyed by freezing with liquid nitrogen usually heals in 3 to 6 weeks. After the procedure, keep the wound clean and dry. A scab will form over the area.

Why It Is Done

Cryosurgery is used more often for precancerous growths such as actinic keratoses than for skin cancer.

Cryosurgery is done to destroy skin cancer if:

How Well It Works

Cryosurgery is the treatment of choice for superficial actinic keratoses. And it often is successful in treating small lesions of squamous cell carcinoma in situ.1

If cryosurgery is used to treat skin cancer, there is a small chance that the skin cancer will return after treatment. One study that followed people for 5 years after treatment found that cryosurgery had a cure rate for 99 out of 100 people.2

Risks

The risks of cryosurgery include:

What To Think About

Cryosurgery is an efficient procedure if there are many skin cancers that need to be destroyed or treated.

Cryosurgery wounds heal slowly and can be painful.

Cryosurgery destroys tissue, so there is no way to obtain a sample (biopsy) for diagnosis.

Complete the surgery information form (PDF) to help you prepare for this surgery.

References

Citations

  1. Habif TP (2010). Premalignant and malignant nonmelanoma skin tumors. In Clinical Dermatology: A Color Guide to Diagnosis and Therapy, 5th ed., pp. 801–846. Edinburgh: Mosby Elsevier.

  2. Carucci JA, et al. (2012). Basal cell carcinoma. In LA Goldman et al., eds., Fitzpatrick's Dermatology in General Medicine, 8th ed., vol. 1, pp. 1294–1303. New York: McGraw-Hill.

Credits for Cryosurgery for Nonmelanoma Skin Cancer

By Healthwise Staff
Primary Medical Reviewer E. Gregory Thompson, MD - Internal Medicine
Specialist Medical Reviewer Amy McMichael, MD - Dermatology
Last Revised October 2, 2012

Note: The "printer friendly" document will not contain all the information available in the online document. Some information (e.g. cross-references to other topics, definitions or medical illustrations) is only available in the online version.

© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.